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~,bstract Glycosaminoglycans ynthesized by human skin 
fibroblasts were simultaneously radiolabelled with D-[1-3H]glu - 
cosamine and Na235SO4. Considering 3H incorporation, we 
t0und that IFNy increased the production of glycosaminoglycan 
synthesis, including hyaluronic acid, heparan and ehondroitin/ 
dermatan sulfate. In contrast, the production of heparan and 
chondroitin/dermatan sulfate was slightly decreased on the basis 
of the 35S signal. Furthermore, when heparan sulfate was treated 
with nitrous acid, the release of free 35S was greater in control 
than in treated cells, although the 3H patterns of depolymeriza- 
tion with this agent were similar. These data demonstrate that 
1FNy inhibits the incorporation of sulfate from extracellular 
medium into heparan sulfate. 
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!. Introduction 
Interferon-gamma (IFNT) is a cytokine having a broad 
raage of activities [1] including antiviral, immunoregulatory 
[21 and antiproliferative [3] properties. It also acts as an in- 
hitfitor of collagen synthesis when added to fibroblasts in 
cu ture [4]. However, the effects of IFN7 on the other compo- 
neats of the matrix (mainly glycoproteins and glycosamino- 
gl 3 cans) remain to be elucidated. Contradictory results have 
be~n published on the quantitative ffect of IFNy on glycosa- 
miaoglycans ynthesized by human skin fibroblasts. Indeed, 
when o-[3H]glucosamine was used for radiolabelling these mo- 
lectdes, an increase in the total production of hyaluronic acid 
antl proteoglycans was found [5]. However, when 35S incor- 
poration was investigated, no increase was observed [6,7]. To 
clarify this discrepancy, we used in this study the two isotopic 
rea~;ents simultaneously for the radiolabelling of sulfated gly- 
cosaminoglycans a sociated with the cell layer of human skin 
fibr,)blasts. 
2. Materials and methods 
2.2. Extraction of hyaluronic acid and proteoglycans jbom cell layer 
Cell-associated proteoglycans were extracted by incubation in 4 M 
guanidine HC1, 0.05 M sodium acetate (pH 6), 2% (v/v) Triton X 100 
for 12 h at 4°C. Solubilized macromolecules were buffer exchanged on 
a Bio-Gel P-6 DG (Bio-Rad) column (2.5 cm × 30 cm) eluted with 20 
mM sodium phosphate buffer, 0.15 M NaCI, 6 M urea, 0.l% CHAPS 
(w/v), pH 6.8, at a flow rate of 1.6 ml/min (fractions of 2.4 ml) 
Proteoglycans were separated on a anion-exchange DEAE Sephacel 
(Pharmacia) column (0.9 cm×6 cm) eluted at a flow rate of 0.2 roll 
min with a 200 ml linear gradient from 0.15 to 0.8 M NaCI in 20 mM 
sodium phosphate, 6 M urea and 0.1% CHAPS, pH 6.8. Fractions 
corresponding toheparan sulfate proteoglycans were pooled, dialyzed 
(Spectra por 6; cut-off 1000, from Spectrum) against distilled water, 
and freeze-dried [8]. 
2.3. Preparation of intact heparan sulfate chains 
Traces of chondroitin sulfate were removed by treatment with 
chondroitinase ABC (EC 4.2.2.4) from Proteus vulgar& supplied by 
Sigma (1 U/ml), in 100 mM Tris-acetate, 100 mM EDTA, pH 8, for 
one night at 37°C. Core proteins were eliminated by two successive 
digestions with papain (1 mg/ml) for 24 h and 5 h at 65°C in 0.1 M 
sodium acetate, 5 mM EDTA, 5 mM cysteine, pH 7.0. Heparan sul- 
fate was recovered in the supernatants of two successive precipitations 
with ice-cold trichloroacetic a id 100% (w/v) added to the extract at a 
final concentration of 10% (v/v) for 30 min at 4°C, followed by cen- 
trifugations at 10000×g for 30 rain at 4°C. After a dialysis against 
0.15 M sodium phosphate buffer, pH 6.8, samples were loaded on a 
2 ml DEAE Sephacel column. After extensive washing with 0.3 M 
NaCI, heparan sulfate chains were obtained by elution with 1 M 
NaC1, dialyzed against distilled water and freeze-dried [8]. 
2.4. Depolymerization f heparan sulfate chains with nitrous acid and 
separation of the resulting oligosaccharides 
Freeze-dried heparan sulfate was submitted to low-pH nitrous acid 
deaminative cleavage following the method of Shively and Conrad [9]. 
Oligosaccharides were resolved by gel filtration chromatography on a 
Bio-Gel P-6 (minus 400 mesh, from Bio-Rad) column (120 cm × 1 cm) 
in 0.5 M NH4HCO3 eluted at a flow rate of 4 ml/h. Aliquots from 1 ml 
fractions were counted by liquid scintillation. Disaccharides were re- 
covered and fractionated on an MonoQ HR5/5 anion exchange col- 
umn (0.5 cm×5 cm) with an FPLC system from Pharmacia. A 15 ml 
linear gradient from 0 to 1 M NaC1 in 10 mM HCI, pH 2.0, was used 
at a flow rate of 1 ml/min. 50 fractions of 0.5 ml were collected, mixed 
with 10 ml of PicoFluor 15 (Packard) and counted in a Tri-Carb 2100 
TR liquid scintillation analyser (Packard). The degree of sulfation was 
identified by co-injection of 1 ~tg of different heparan sulfate disac- 
charide standards. 
2.1. Cell culture, IFNy treatment and radiolabelling 
Children's kin flbroblasts were cultured at 37°C (5% CO2 in air) in 
DMEM 25 mM HEPES (Gibco), supplemented with 10% (v/v) fetal 
calf-,erum (heat inactivated), penicillin (100 U/ml) and streptomycin 
(100 ag/ml). Cells were grown to confluence at the ffth passage in two 
75-cH 2 flasks (Falcon, UK). One flask was washed and received fresh 
medi am with 1% of serum and 250 U/ml of IFN 7 (Roussel Uclaf, RU 
4236t~) for 24 h. The other flask (control) received the same medium 
withc~ut IFNy. Cells were then allowed to incorporate for 36 h 
D-[1-:H]glucosamine (32 ~Ci/ml) and Na235SO4 (32 ~tCi/rnl) pur- 
chased from Amersham International, in DMEM devoid of sulfate. 
*Cortesponding author. Fax: (33) 78.61.13.45. 
3. Results 
In the total cell extract, we compared the glycosaminogly- 
can production by control and IFNy-treated cells. We calcu- 
lated the treated/untreated ratios for each isotope used for the 
radiolabelling and obtained a value of 3.07 for D-[1- 
3H]glucosamine against only 0.88 for Na23'~SO4 (data not 
shown). It thus seems plausible that IFNy increases in higher 
proportion hyaluronic acid (unsulfated glycosaminoglycan) i  
comparison with sulfated proteoglycans (with heparan and/or 
chondroitin/dermatan sulfate side chains). To evaluate the 
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Fig. 1. Fractionation of radiolabelled hyaluronic acid and sulfated 
proteoglycans bychromatography onDEAE Sephacel. The order of 
elution in the 200 ml linear gradient from 0.15 to 0.8 M NaCI 
( . . . . .  ) was hyaluronic acid (HA), heparan sulfate proteoglycans 
(HSPGs) and chondroitin/dermatan sulfate proteoglycans (CS/ 
DSPGs). Superposition f the 3H (a) and 35S signals (b) for control 
( ) and IFNT-treated cells (- - -). The ratio between IFNy-trea- 
ted and control cells is indicated in bold letters above ach peak. 
IFN7 effect on individual glycosaminoglycans, the cell extract 
was fractionated by anion exchange chromatography (Fig. 1). 
IFN 7 induced a 6.52- and 2.22-fold increase in the aH signal 
found in hyaluronic acid and sulfated glycosaminoglycans 
(heparan sulfate and chondroitin/dermatan sulfate) peaks, re- 
spectively (Fig. la). In contrast, the extent of 3~S incorpora- 
tion was slightly reduced in the sulfated proteoglycans after 
IFN 7 treatment (Fig. lb). This led to a decrease in the 35S/3H 
ratio for sulfated proteoglycans from 0.24 for control cells to 
0.09 for treated cells. This shift in the 35S/3H ratio was almost 
identical for purified heparan sulfate chains (0.23 and 0.10, 
respectively) and therefore was not related to changes in the 
degree of glycosylation of the core proteins. 
At this stage of our study, the data were consistent with the 
hypothesis that IFNy decreases the number of N- and/or O- 
sulfations on heparan sulfate chains. In order to characterize 
the N-sulfation on these chains, we analyzed the nitrous acid 
pattern of depolymerization f heparan sulfate isolated either 
from control or IFNT-treated cells (Fig. 2). This agent cleaves 
each N-sulfated glucosamine with the concomitant release of 
the N-sulfate associated group [9]. Considering the 3H signal, 
identical patterns of cleavage were obtained (Fig. 2a), demon- 
strating that IFN7 did not induce changes in the number and 
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Fig. 2. Bio-Gel P-6 gel filtration of oligosaccharides produced by 
low-pH nitrous acid deaminative cleavage on heparan sulfate chains. 
(a) Superposition of the ZH signal for control ( ) and IFNT- 
treated cells (---). (b) Superposition of the 3~S signal for control 
( ) and IFNy treated cells (- - -). The degree of polymerization 
(2, disaccharides; 4, tetrasaccharides,...) is indicated above each 
peak. 
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~ig. 3. FPLC fractionation on a MonoQ column of disaccharides 
,,enerated by low-pH nitrous acid deaminative cleavage on heparan 
,ulfate chains. N-desulfated isaccharides (peak 2 of Fig. 2a) were 
~eparated through a 15 ml linear gradient ( . . . . .  ) from 0 to 1 M 
"qaC1 as a function of their degree of O-sulfation (Non-S, non-sul- 
fated; Mono-S, monosulfated; Di-S, disulfated). (a) Superposi- 
ion of 3H ( ) and 35S (- - - )  signals for control cell layer. 
b) Superposition of 3H ( ) and 35S (- - -) signals for treated 
ell layer. The indicated percentages correspond to the contribution 
,f each disaccharide to the total collected radioactivity. 
change column (Fig. 3). IFNy did not lead to any significant 
change in the proportion of the different disaccharides sepa- 
rated as a function of their degree of O-sulfation (non-, 
mono- or di-sulfated which represent 51, 41 and 8%, respec- 
tively, of the total collected radioactivity). Therefore, the shift 
in 35S signal induced by IFNy could not be attributed to a 
change in O-sulfation. The asS signal did not coelute with any 
disaccharide standard (Fig. 3a,b) and corresponded to free 
sulfate liberated by the action of nitrous acid [11]. Therefore, 
IFNq( does not change the overall sulfation in heparan sulfate, 
but inhibits the incorporation of sulfate from the extracellular 
medium into this glycosaminoglycan. 
4. Discussion 
The present data demonstrate hat IFN 7 interferes with the 
incorporation of radioactive sulfate from the extracellular 
medium in heparan sulfate synthesized by human skin fibro- 
blasts. Nevertheless, the cytokine does not affect the O- and 
N-sulfation of this glycosaminoglycan. This suggests that cells 
use endogenous sulfate for the synthesis of their heparan sul- 
fate chains in the presence of IFNy. In mammals, the sources 
of sulfate include diet, breakdown of proteins followed by 
oxidation of the resulting sulfur amino acids, and turn-over 
of glycosaminoglycans. Exogenous ulfate is transported into 
cells by proton/sulfate or sodium/sulfate symporters [12]. 
Then, this inorganic sulfate is activated into adenosine 3'- 
phosphate 5'-phosphosulfate (PAPS) by concerted action of 
the two enzymes ATP-sulfurylase and APS kinase [13,14]. The 
cytosolic product PAPS is then translocated in the lumen of 
the Golgi apparatus through a PAPS/3'-AMP antiport pro- 
tein [15], where it acts as the sulfate donor in numerous ulfo- 
transferase reactions [16]. Since IFN7 does not lead to an 
undersulfation of heparan sulfate chains, it should not affect 
any of the intracellular molecules involved in sulfate metabo- 
lism, but rather the plasma membrane transport systems (pro- 
ton/sulfate or sodium/sulfate symporters). More work will be 
required to investigate a possible regulation of this transport 
systems by IFNy. 
An alternative hypothesis could also explain the effect of 
the cytokine on sulfate incorporation. Indeed, IFN7 increases 
hyaluronic acid in high proportions, and it has been demon- 
strated that this molecule inhibits sulfate incorporation in 
sulfate glycosaminoglycans sythesized by isolated adult chon- 
drocytes [17]. 
Taken together, the present data provide a rational expla- 
nation for the discrepant results published about the effects of 
IFN 7 on glycosaminoglycans. Whatever the stage affected by 
IFN 7 in sulfate metabolism, this study highlights the fact that 
experiments realized with 35S incorporation following IFN7 
treatment should be considered with caution. 
,listribution of N-sulfated glucosamines. However, IFN T led 
io a strong decrease in the 35S signal (Fig. 2b). The 35S signal 
was essentially detected in the disaccharide fractions, which 
was consistent with the fact that sulfated disaccharides are 
mainly present in the nitrous acid sensitive sequences in he- 
paran sulfate chains [10]. In order to determine whether this 
~S signal arose from cleavage of N-sulfate groups by nitrous 
acid, or was incorporated in O-sulfate groups in disaccharides, 
lhis material was further analyzed on a MonoQ anion ex- 
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